Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP+AS vs Chloroquine for Vivax Malaria in Afghanistan
NCT00486694Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of sulfadoxine + pyrimethamine and artesunate in vivax malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Proportion of patients with parasitological cure at 28 days. Started Mar 2004; status: completed.
02
Drugs
sulfadoxine + pyrimethamineartesunate
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT00486694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486694.